GSE125014 enzalutamide prostate gland 1 v 5 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE125014_enzalutamide_prostate gland_1_v_5_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE125014_enzalutamide_prostate gland_1_v_5_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE125014_enzalutamide_prostate gland_1_v_5_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE125014_enzalutamide_prostate gland_1_v_5_human_up.

Results found

Linked to

 

Label

Description

 

Gene

H2B clustered histone 8

Gene

vesicle associated membrane protein 7

Gene

H3.3 histone A

Gene

H2A clustered histone 19

Gene

gametogenetin binding protein 2

Gene

H3.7 histone (putative)

Gene

non-coding RNA activated by DNA damage

Gene

CASTOR family member 3, pseudogene

Gene

dehydrogenase/reductase X-linked

Gene

ATPase H+ transporting V1 subunit G2

  • Gene

    H2B clustered histone 8


  • Gene

    vesicle associated membrane protein 7



  • Gene

    H2A clustered histone 19


  • Gene

    gametogenetin binding protein 2


  • Gene

    H3.7 histone (putative)


  • Gene

    non-coding RNA activated by DNA damage


  • Gene

    CASTOR family member 3, pseudogene


  • Gene

    dehydrogenase/reductase X-linked


  • Gene

    ATPase H+ transporting V1 subunit G2

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.